All news

Pacira merger clears tender threshold without vote

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Viatris subsidiary Peach Purchaser Sub's $36.50-per-share tender offer for Pacira BioSciences concluded with roughly 66.46% of outstanding shares validly tendered, clearing the minimum condition. The purchaser will merge into Pacira on November 17, 2026, without a stockholder vote, after which Pacira shares will be delisted from Nasdaq.

Read original source

PCRX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.